We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCS
2201
DELISTED
Steelcase
SCS
| $2.74M | ﹤0.01% |
420,583
-9,552
| -2% | -$102K |
|
|
MFA
2202
MFA Financial
MFA
$933M
| $2.74M | ﹤0.01% |
351,726
-10,520
| -3% | -$118K |
|
|
JKS
2203
JinkoSolar
JKS
$891M
| $2.74M | ﹤0.01% |
49,400
+2,200
| +5% | +$135K |
|
2204
National Beverage
FIZZ
$3.01B
| $2.73M | ﹤0.01% |
70,719
-832
| -1% | -$41.6K |
|
|
OLO
2205
DELISTED
Olo Inc
OLO
| $2.72M | ﹤0.01% |
344,595
-10,481
| -3% | -$100K |
|
2206
Liberty Global Class A
LBTYA
$3.6B
| $2.71M | ﹤0.01% |
173,946
-128,940
| -43% | -$2.59M |
|
2207
Mesa Laboratories
MLAB
$574M
| $2.71M | ﹤0.01% |
19,254
-454
| -2% | -$82.8K |
|
2208
Washington Trust Bancorp
WASH
$741M
| $2.7M | ﹤0.01% |
58,175
-1,363
| -2% | -$69.7K |
|
|
ABTX
2209
DELISTED
Allegiance Bancshares
ABTX
| $2.7M | ﹤0.01% |
64,855
-2,968
| -4% | -$127K |
|
|
SNBR
2210
DELISTED
Sleep Number
SNBR
| $2.7M | ﹤0.01% |
79,813
-1,631
| -2% | -$65.4K |
|
2211
Compass
COMP
$9.66B
| $2.69M | ﹤0.01% |
1,161,725
+396,311
| +52% | +$1.41M |
|
2212
Lufax Holding
LU
$1.3B
| $2.68M | ﹤0.01% |
264,160
-55,675
| -17% | -$951K |
|
2213
BP
BP
$107B
| $2.68M | ﹤0.01% |
93,900
-78,700
| -46% | -$2.34M |
|
2214
Camden National
CAC
$976M
| $2.68M | ﹤0.01% |
62,884
+3,958
| +7% | +$180K |
|
2215
Sterling Infrastructure
STRL
$16.7B
| $2.68M | ﹤0.01% |
124,757
-2,635
| -2% | -$63.3K |
|
2216
Zentalis Pharmaceuticals
ZNTL
$302M
| $2.68M | ﹤0.01% |
123,566
+11,239
| +10% | +$307K |
|
2217
Blink Charging
BLNK
$87.9M
| $2.67M | ﹤0.01% |
150,896
-3,116
| -2% | -$64K |
|
|
RAD
2218
DELISTED
Rite Aid Corporation
RAD
| $2.67M | ﹤0.01% |
539,703
+345,455
| +178% | +$2.68M |
|
|
FBMS
2219
DELISTED
The First Bancshares, Inc.
FBMS
| $2.67M | ﹤0.01% |
89,356
-213
| -0.2% | -$6.37K |
|
2220
Orthofix Medical
OFIX
$419M
| $2.67M | ﹤0.01% |
139,543
-12,321
| -8% | -$277K |
|
2221
Skillsoft
SKIL
$81.6M
| $2.67M | ﹤0.01% |
72,874
-3,196
| -4% | -$219K |
|
|
AMBR
2222
Amber International Holding Ltd
AMBR
$130M
| $2.67M | ﹤0.01% |
761,225
-17,259
| -2% | -$87.5K |
|
|
VCSA
2223
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
| $2.67M | ﹤0.01% |
43,409
+38,844
| +851% | +$2.69M |
|
2224
Rigel Pharmaceuticals
RIGL
$750M
| $2.66M | ﹤0.01% |
225,747
-83,817
| -27% | -$1.13M |
|
|
TUP
2225
DELISTED
Tupperware Brands Corporation
TUP
| $2.66M | ﹤0.01% |
405,683
-12,687
| -3% | -$114K |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.